Illumina (ILU) Stock Forecast & Price Target

12 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ILU Analyst Ratings

Moderate Buy

8 Buy

5 Hold

3 Sell

Based on 16 analysts giving stock ratings to

Illumina

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ILU Stock 12 Month Forecast

Average Price Target

€166.52

▼(-1.76% Downside)

Based on 16 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is €166.52 with a high forecast of €199.02 and a low forecast of €97.78. The average price target represents a -1.76% change from the last price of €169.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"80":"€80","110":"€110","140":"€140","170":"€170","200":"€200"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":199.0182341,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€199.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":166.51552793312501,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€166.52</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.77852371,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€97.78</span>\n  </div></div>","useHTML":true}}],"tickPositions":[80,110,140,170,200],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.7,171.95524877692307,174.21049755384615,176.46574633076924,178.7209951076923,180.97624388461537,183.23149266153845,185.48674143846154,187.74199021538462,189.9972389923077,192.25248776923075,194.50773654615384,196.76298532307692,{"y":199.0182341,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.7,169.4550406102404,169.21008122048076,168.96512183072116,168.72016244096153,168.47520305120193,168.2302436614423,167.9852842716827,167.74032488192307,167.49536549216347,167.25040610240384,167.00544671264424,166.76048732288461,{"y":166.51552793312501,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,169.7,164.16757874692306,158.63515749384615,153.10273624076922,147.5703149876923,142.03789373461538,136.50547248153845,130.97305122846154,125.44062997538461,119.90820872230769,114.37578746923077,108.84336621615384,103.31094496307692,{"y":97.77852371,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":82.91,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.42,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.3,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.74,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":111.48,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":114.38,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":119.4,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":112.02,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.06,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.32,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":138.7,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.4,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.7,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€199.02

Average Price Target€166.52

Lowest Price Target€97.78

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael Ryskin

Bank of America Securities

€121.14

Sell

-28.53%

Downside

Reiterated

08/05/26

Illumina: One-Time Consumables Boost Masks Weak Underlying Demand; Sell Rating Reiterated with Unchanged $140 Price Target

Ilya Zubkov

Freedom Capital Markets

€134.12→€160.08

Hold

-5.56%

Downside

Downgraded

08/05/26

Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker

Daniel Arias

Stifel Nicolaus

€194.69

Buy

14.86%

Upside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Casey Woodring

J.P. Morgan

€199.02

Buy

17.41%

Upside

Reiterated

08/04/26

J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)

David Westenberg

Piper Sandler

€173.06→€194.69

Buy

14.86%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)

Kyle Mikson CFA

Canaccord Genuity

€164.41→€177.39

Hold

4.65%

Upside

Reiterated

08/03/26

Canaccord Genuity Remains a Hold on Illumina (ILMN)

Patrick B Donnelly

Citi

€82.2→€97.78

Sell

-42.31%

Downside

Reiterated

08/03/26

Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi

Daniel Brennan

TD Cowen

€166.14→€181.71

Hold

7.20%

Upside

Assigned

07/31/26

TD Cowen Keeps Their Hold Rating on Illumina (ILMN)

Eve Burstein

Bernstein

€160.08→€186.04

Hold

9.76%

Upside

Reiterated

07/31/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)

Luke Sergott

Barclays

€125.47→€138.45

Sell

-18.32%

Downside

Reiterated

07/31/26

Barclays Sticks to Its Sell Rating for Illumina (ILMN)

Subbu Nambi

Guggenheim

€173.06→€195.56

Buy

15.37%

Upside

Reiterated

07/30/26

Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim

Dan Leonard

RBC Capital

€147.1→€199.02

Buy

17.41%

Upside

Assigned

07/30/26

RBC Capital Keeps Their Buy Rating on Illumina (ILMN)

Puneet Souda

Leerink Partners

€151.43→€181.71

Buy

7.20%

Upside

Reiterated

07/17/26

Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)

Vijay Kumar

Evercore ISI

€134.12→€173.06

Buy

2.10%

Upside

Reiterated

07/06/26

Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI

Tycho Peterson

Jefferies

€129.79

Hold

-23.43%

Downside

Reiterated

07/01/26

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Illumina (NASDAQ: ILMN) and Protara Therapeutics (NASDAQ: TARA)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael Ryskin

Bank of America Securities

€121.14

Sell

-28.53%

Downside

Reiterated

08/05/26

Illumina: One-Time Consumables Boost Masks Weak Underlying Demand; Sell Rating Reiterated with Unchanged $140 Price Target

Ilya Zubkov

Freedom Capital Markets

€134.12→€160.08

Hold

-5.56%

Downside

Downgraded

08/05/26

Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker

Daniel Arias

Stifel Nicolaus

€194.69

Buy

14.86%

Upside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Casey Woodring

J.P. Morgan

€199.02

Buy

17.41%

Upside

Reiterated

08/04/26

J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)

David Westenberg

Piper Sandler

€173.06→€194.69

Buy

14.86%

Upside

Reiterated

08/03/26

Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)

Kyle Mikson CFA

Canaccord Genuity

€164.41→€177.39

Hold

4.65%

Upside

Reiterated

08/03/26

Canaccord Genuity Remains a Hold on Illumina (ILMN)

Patrick B Donnelly

Citi

€82.2→€97.78

Sell

-42.31%

Downside

Reiterated

08/03/26

Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi

Daniel Brennan

TD Cowen

€166.14→€181.71

Hold

7.20%

Upside

Assigned

07/31/26

TD Cowen Keeps Their Hold Rating on Illumina (ILMN)

Eve Burstein

Bernstein

€160.08→€186.04

Hold

9.76%

Upside

Reiterated

07/31/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)

Luke Sergott

Barclays

€125.47→€138.45

Sell

-18.32%

Downside

Reiterated

07/31/26

Barclays Sticks to Its Sell Rating for Illumina (ILMN)

Subbu Nambi

Guggenheim

€173.06→€195.56

Buy

15.37%

Upside

Reiterated

07/30/26

Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim

Dan Leonard

RBC Capital

€147.1→€199.02

Buy

17.41%

Upside

Assigned

07/30/26

RBC Capital Keeps Their Buy Rating on Illumina (ILMN)

Puneet Souda

Leerink Partners

€151.43→€181.71

Buy

7.20%

Upside

Reiterated

07/17/26

Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)

Vijay Kumar

Evercore ISI

€134.12→€173.06

Buy

2.10%

Upside

Reiterated

07/06/26

Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI

Tycho Peterson

Jefferies

€129.79

Hold

-23.43%

Downside

Reiterated

07/01/26

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Illumina (NASDAQ: ILMN) and Protara Therapeutics (NASDAQ: TARA)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

TNYATenaya Therapeutics

JBIOJade Biosciences

GHRSGH Research

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months

Patrick B DonnellyCiti

Success Rate

10/17 ratings generated profit

Average Return

-0.34%

Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of -0.34% per trade.

1 Year

Vijay KumarEvercore ISI

Success Rate

11/18 ratings generated profit

Average Return

+22.57%

Copying Vijay Kumar's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +22.57% per trade.

2 Years

Vijay KumarEvercore ISI

Success Rate

12/18 ratings generated profit

Average Return

+31.64%

Copying Vijay Kumar's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +31.64% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILU Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ILU has received 14 Buy Ratings, 9 Hold Ratings, and 5 Sell Ratings. ILU average Analyst price target in the past 3 months is 166.52.

Each month's total comprises the sum of three months' worth of ratings.

ILU Financial Forecast

ILU Earnings Forecast

Next quarter’s earnings estimate for ILU is €1.18 with a range of €1.15 to €1.20. The previous quarter’s EPS was €1.14. ILU beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.16% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.

ILU Sales Forecast

Next quarter’s sales forecast for ILU is €998.94M with a range of €983.22M to €1.01B. The previous quarter’s sales results were €1.01B. ILU beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.32% of the time in the same period. In the last calendar year ILU has Performed in-line its overall industry.

ILU Stock Forecast FAQ

What is DE:ILU’s average 12-month price target, according to analysts?

Based on analyst ratings, Illumina’s 12-month average price target is 166.52.

What is DE:ILU’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:ILU, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Illumina a Buy, Sell or Hold?

Illumina has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 5 hold ratings and 3 sell ratings.

What is Illumina’s share price target?

The average share price target for Illumina is 166.52. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €199.02 ,and the lowest forecast is €97.78. The average share price target represents -1.76% Decrease from the current price of €169.5.

What do analysts say about Illumina?

Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of Illumina?

To buy shares of DE:ILU, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Illumina (ILU) Stock Forecast & Price Target

ILU Analyst Ratings

ILU Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Illumina

ILU Analyst Recommendation Trends

ILU Financial Forecast

ILU Earnings Forecast

ILU Sales Forecast

ILU Stock Forecast FAQ

Detailed List of Analyst Forecasts